Origin, evolution and innate immune control of simian foamy viruses in humans

Current Opinion in Virology

Volumn 10, Issue , 2015, Pages 47-55

  Rua, Rejane ^a,b,c   Gessain, Antoine ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; STRUCTURAL PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; GENETIC CONSERVATION; GENETIC ORGANIZATION; GENETIC STABILITY; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION RISK; INNATE IMMUNITY; MOLECULAR EVOLUTION; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; RISK ASSESSMENT; RISK FACTOR; SIMIAN FOAMY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VIRAL TROPISM; VIRUS EXPRESSION; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS RECOMBINATION; VIRUS TRANSMISSION; ZOONOSIS; ANIMAL; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PRIMATE; PRIMATE DISEASE; TRANSMISSION; ULTRASTRUCTURE; VETERINARY; VIROLOGY;

ANIMALS; DNA, VIRAL; EVOLUTION, MOLECULAR; GENOME, VIRAL; HUMANS; PRIMATE DISEASES; PRIMATES; RETROVIRIDAE INFECTIONS; SIMIAN FOAMY VIRUS; VIRAL STRUCTURAL PROTEINS; VIRAL TROPISM; ZOONOSES;

EID: 84923076152     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2014.12.003     Document Type: Review

References (62)

1. N.D. Wolfe, C.P. Dunavan, and J. Diamond Origins of major human infectious diseases Nature 447 2007 279 283
2. S. Locatelli, and M. Peeters Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population AIDS 26 2012 659 673
3. J.F. Enders, and T.C. Peebles Propagation in tissue cultures of cytopathogenic agents from patients with measles Proc Soc Exp Biol Med 86 1954 277 286
4. S.M. Murray, L.J. Picker, M.K. Axthelm, K. Hudkins, C.E. Alpers, and M.L. Linial Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections J Virol 82 2008 5981 5985
5. A. Choudhary, T.A. Galvin, D.K. Williams, J. Beren, M.A. Bryant, and A.S. Khan Influence of naturally occurring simian foamy viruses (SFVs) on SIV disease progression in the rhesus macaque (Macaca mulatta) model Viruses 5 2013 1414 1430
6. B.G. Achong, P.W. Mansell, and M.A. Epstein A new human virus in cultures from a nasopharyngeal carcinoma J Pathol 103 1971 P18
7. S.M. Murray, and M.L. Linial Foamy virus infection in primates J Med Primatol 35 2006 225 235
8. A. Gessain, R. Rua, E. Betsem, J. Turpin, and R. Mahieux HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology Virology 435 2013 187 199
9. C.D. Meiering, and M.L. Linial Historical perspective of foamy virus epidemiology and infection Clin Microbiol Rev 14 2001 165 176
10. M. Schweizer, R. Turek, H. Hahn, A. Schliephake, K.O. Netzer, G. Eder, M. Reinhardt, A. Rethwilm, and D. Neumann-Haefelin Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans AIDS Res Hum Retroviruses. 11 1995 161 170
11. N.D. Wolfe, W.M. Switzer, J.K. Carr, V.B. Bhullar, V. Shanmugam, U. Tamoufe, A.T. Prosser, J.N. Torimiro, A. Wright, and E. Mpoudi-Ngole Naturally acquired simian retrovirus infections in central African hunters Lancet 363 2004 932 937
12. E. Betsem, R. Rua, P. Tortevoye, A. Froment, and A. Gessain Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa PLoS Pathog 7 2011 e1002306
13. A. Mouinga-Ondeme, M. Caron, D. Nkoghe, P. Telfer, P. Marx, A. Saib, E. Leroy, J.P. Gonzalez, A. Gessain, and M. Kazanji Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa J Virol 86 2012 1255 1260
14. W.M. Switzer, S. Tang, S. Ahuka-Mundeke, A. Shankar, D.L. Hanson, H. Zheng, A. Ayouba, N.D. Wolfe, M. LeBreton, and C.F. Djoko Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo Retrovirology 9 2012 100
15. L. Jones-Engel, C.C. May, G.A. Engel, K.A. Steinkraus, M.A. Schillaci, A. Fuentes, A. Rompis, M.K. Chalise, N. Aggimarangsee, and M.M. Feeroz Diverse contexts of zoonotic transmission of simian foamy viruses in Asia Emerg Infect Dis 14 2008 1200 1208
16. G.A. Engel, C.T. Small, K. Soliven, M.M. Feeroz, X.X. Wang, M.K. Hasan, G. Oh, S.M.R. Alam, K.L. Craig, and D.L. Jackson Zoonotic simian foamy virus in Bangladesh reflects diverse patterns of transmission and co-infection Emerg Microbes Infect 2013 2
17. L. Jones-Engel, G.A. Engel, M.A. Schillaci, A. Rompis, A. Putra, K.G. Suaryana, A. Fuentes, B. Beer, S. Hicks, and R. White Primate-to-human retroviral transmission in Asia Emerg Infect Dis 11 2005 1028 1035
18. A. Rethwilm Molecular biology of foamy viruses Med Microbiol Immunol 199 2010 197 207
19. K. Plochmann, A. Horn, E. Gschmack, N. Armbruster, J. Krieg, T. Wiktorowicz, C. Weber, K. Stirnnagel, D. Lindemann, and A. Rethwilm Heparan sulfate is an attachment factor for foamy virus entry J Virol 86 2012 10028 10035
20. J.A. Mikovits, P.M. Hoffman, A. Rethwilm, and F.W. Ruscetti In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus J Virol 70 1996 2774 2780
21. S.F. Yu, J. Stone, and M.L. Linial Productive persistent infection of hematopoietic cells by human foamy virus J Virol 70 1996 1250 1254
22. S.M. Murray, L.J. Picker, M.K. Axthelm, and M.L. Linial Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression J Virol 80 2006 663 670
23. K. Soliven, X. Wang, C.T. Small, M.M. Feeroz, E.G. Lee, K.L. Craig, K. Hasan, G.A. Engel, L. Jones-Engel, and FAt Matsen Simian foamy virus infection of rhesus macaques in Bangladesh: relationship of latent proviruses and transcriptionally active viruses J Virol 87 2013 13628 13639
24. R. Rua, E. Betsem, and A. Gessain Viral latency in blood and saliva of simian foamy virus-infected humans PLoS One 8 2013 e77072
25. M.E. Callahan, W.M. Switzer, A.L. Matthews, B.D. Roberts, W. Heneine, T.M. Folks, and P.A. Sandstrom Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene J Virol 73 1999 9619 9624
26. D. von Laer, D. Neumann-Haefelin, J.L. Heeney, and M. Schweizer Lymphocytes are the major reservoir for foamy viruses in peripheral blood Virology 221 1996 240 244
27. R. Rua, E. Betsem, T. Montange, F. Buseyne, and A. Gessain In vivo cellular tropism of gorilla simian foamy virus in blood of infected humans J Virol 88 2014 13429 13435
28. M. Schweizer, H. Schleer, M. Pietrek, J. Liegibel, V. Falcone, and D. Neumann-Haefelin Genetic stability of foamy viruses: long-term study in an African green monkey population J Virol 73 1999 9256 9265
29. W.M. Switzer, M. Salemi, V. Shanmugam, F. Gao, M.E. Cong, C. Kuiken, V. Bhullar, B.E. Beer, D. Vallet, and A. Gautier-Hion Ancient co-speciation of simian foamy viruses and primates Nature 434 2005 376 380
30. S. Cleaveland, D.T. Haydon, and L. Taylor Overviews of pathogen emergence: which pathogens emerge, when and why? Curr Top Microbiol Immunol 5 3 2007 85 111
31. R. Rua, E. Betsem, S. Calattini, A. Saib, and A. Gessain Genetic characterization of simian foamy viruses infecting humans J Virol 86 2012 13350 13359
32. M. Schmidt, O. Herchenroder, J. Heeney, and A. Rethwilm Long terminal repeat U3 length polymorphism of human foamy virus Virology 230 1997 167 178
33. F.H. Leendertz, F. Zirkel, E. Couacy-Hymann, H. Ellerbrok, V.A. Morozov, G. Pauli, C. Hedemann, P. Formenty, S.A. Jensen, and C. Boesch Interspecies transmission of simian foamy virus in a natural predator-prey system J Virol 82 2008 7741 7744
34. W. Liu, M. Worobey, Y. Li, B.F. Keele, F. Bibollet-Ruche, Y. Guo, P.A. Goepfert, M.L. Santiago, J.B. Ndjango, and C. Neel Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees PLoS Pathog 4 2008 e1000097
35. A. Blasse, S. Calvignac-Spencer, K. Merkel, A.S. Goffe, C. Boesch, R. Mundry, and F.H. Leendertz Mother-offspring transmission and age-dependent accumulation of simian foamy virus in wild chimpanzees J Virol 87 2013 5193 5204
36. M.M. Feeroz, K. Soliven, C.T. Small, G.A. Engel, A. Pacheco, J. Yee, X.X. Wang, M.K. Hasan, G. Oh, and K. Levine Population dynamics of rhesus macaques and associated foamy virus in Bangladesh Emerg Microbes Infect 2 2013 e29
37. T.A. Galvin, I.A. Ahmed, M. Shahabuddin, T. Bryan, and A.S. Khan Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from Macaca cyclopis J Virol 87 2013 8792 8797
38. A. Sabile, A. Rhodes-Feuillette, F.Z. Jaoui, J. Tobaly-Tapiero, M.L. Giron, J. Lasneret, J. Peries, and M. Canivet In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus Res Virol 147 1996 29 37
39. R. Rua, A. Lepelley, A. Gessain, and O. Schwartz Innate sensing of foamy viruses by human hematopoietic cells J Virol 86 2012 909 918
40. R.A. Russell, H.L. Wiegand, M.D. Moore, A. Schafer, M.O. McClure, and B.R. Cullen Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors J Virol 79 2005 8724 8731
41. M. Lochelt, F. Romen, P. Bastone, H. Muckenfuss, N. Kirchner, Y.B. Kim, U. Truyen, U. Rosler, M. Battenberg, and A. Saib The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein Proc Natl Acad Sci U S A 102 2005 7982 7987
42. M. Perkovic, S. Schmidt, D. Marino, R.A. Russell, B. Stauch, H. Hofmann, F. Kopietz, B.P. Kloke, J. Zielonka, and H. Strover Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet J Biol Chem 284 2009 5819 5826
43. A.A. Jaguva Vasudevan, M. Perkovic, Y. Bulliard, K. Cichutek, D. Trono, D. Haussinger, and C. Munk Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3 G J Virol 87 2013 9030 9040
44. F. Delebecque, R. Suspene, S. Calattini, N. Casartelli, A. Saib, A. Froment, S. Wain-Hobson, A. Gessain, J.P. Vartanian, and O. Schwartz Restriction of foamy viruses by APOBEC cytidine deaminases J Virol 80 2006 605 614
45. Matsen FAt, C.T. Small, K. Soliven, G.A. Engel, M.M. Feeroz, X. Wang, K.L. Craig, M.K. Hasan, M. Emerman, and M.L. Linial A novel Bayesian method for detection of APOBEC3-mediated hypermutation and its application to zoonotic transmission of simian foamy viruses PLoS Comput Biol 10 2014 e1003493
46. X. Hu, W. Yang, R. Liu, Y. Geng, W. Qiao, and J. Tan N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm J Virol 88 2014 7036 7044
47. J. Tan, W. Qiao, J. Wang, F. Xu, Y. Li, J. Zhou, Q. Chen, and Y. Geng IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus J Virol 82 2008 4275 4283
48. F. Xu, J. Tan, R. Liu, D. Xu, Y. Li, Y. Geng, C. Liang, and W. Qiao Tetherin inhibits prototypic foamy virus release Virol J 8 2011 198
49. I. Dietrich, E.L. McMonagle, S.J. Petit, S. Vijayakrishnan, N. Logan, C.N. Chan, G.J. Towers, M.J. Hosie, and B.J. Willett Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection J Virol 85 2011 5840 5852
50. B. Pacheco, A. Finzi, K. McGee-Estrada, and J. Sodroski Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins J Virol 84 2010 4095 4099
51. M.W. Yap, D. Lindemann, N. Stanke, J. Reh, D. Westphal, H. Hanenberg, S. Ohkura, and J.P. Stoye Restriction of foamy viruses by primate Trim5 alpha J Virol 82 2008 5429 5439
52. T. Gramberg, T. Kahle, N. Bloch, S. Wittmann, E. Mullers, W. Daddacha, H. Hofmann, B. Kim, D. Lindemann, and N.R. Landau Restriction of diverse retroviruses by SAMHD1 Retrovirology 10 2013 26
53. D.K. Williams, and A.S. Khan Role of neutralizing antibodies in controlling simian foamy virus transmission and infection Transfusion 50 2010 200 207
54. J.E. Cummins Jr., R.S. Boneva, W.M. Switzer, L.L. Christensen, P. Sandstrom, W. Heneine, L.E. Chapman, and C.S. Dezzutti Mucosal and systemic antibody responses in humans infected with simian foamy virus J Virol 79 2005 13186 13189
55. D. Neumann-Haefelin, A. Rethwilm, G. Bauer, F. Gudat, and H. zur Hausen Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells Med Microbiol Immunol 172 1983 75 86
56. M. Schweizer, V. Falcone, J. Gange, R. Turek, and D. Neumann-Haefelin Simian foamy virus isolated from an accidentally infected human individual J Virol 71 1997 4821 4824
57. V. Falcone, M. Schweizer, A. Toniolo, D. Neumann-Haefelin, and A. Meyerhans Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects J Virol 73 1999 1724 1728
58. S. Colas, J.F. Bourge, J. Wybier, M.K. Chelbi-Alix, P. Paul, and R. Emanoil-Ravier Human foamy virus infection activates class I major histocompatibility complex antigen expression J Gen Virol 76 Pt 3 1995 661 667
59. C.R. Bangham CTL quality and the control of human retroviral infections Eur J Immunol 39 2009 1700 1712
60. W.M. Switzer, A.D. Garcia, C. Yang, A. Wright, M.L. Kalish, T.M. Folks, and W. Heneine Coinfection with HIV-1 and simian foamy virus in West Central Africans J Infect Dis 197 2008 1389 1393
61. B. McCloskey, O. Dar, A. Zumla, and D.L. Heymann Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread Lancet Infect Dis 14 2014 1001 1010
62. S. Calattini, E.B. Betsem, A. Froment, P. Mauclere, P. Tortevoye, C. Schmitt, R. Njouom, A. Saib, and A. Gessain Simian foamy virus transmission from apes to humans, rural Cameroon Emerg Infect Dis 13 2007 1314 1320